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Abstract 
Sphingolipid metabolites including ceramide, sphingosine (Sph), and sphingosine-1-phosphate (S1P) 
play important roles in the regulation of cell survival and death. Sphingosine kinase (Sk) phosphorylates Sph to 
S1P. Sk is reportedly overexpressed in various cancer cells, and Sk inhibitors are therefore a target of anti-tumor 
therapy. However, the effects of Sph and Sk inhibitors on cochlear hair cells were unknown. In the present study, 
expression of Sk isotypes in the cochlea was examined. In addition, the changes in Sk activity induced by 
cisplatin (CDDP) and the effects of an Sk inhibitor, Sph and S1P on CDDP ototoxicity were investigated using 
tissue culture techniques. Cochleae were dissected from Sprague-Dawley rats on postnatal days 3 to 5. Organ of 
Corti explants were exposed to 5 μM CDDP for 48 h with or without the Sk inhibitor, Sph, or S1P. Both Sk1 and 
Sk2 were expressed in the normal cochlea. CDDP activated Sk. The Sk inhibitor itself caused hair cell loss at a 
high concentration, and at lower concentrations it increased CDDP-induced hair cell loss. Sph itself also induced 
hair cell death and increased hair cell loss induced by CDDP. However, S1P decreased hair cell loss induced by 
CDDP. Sk inhibitor has the function by increasing ototoxic Sph and decreasing otoprotective S1P, and therefore 
potentially cause ototoxicity. Consideration of the possibility of ototoxicity is required in the usage of Sk 
inhibitors. 
Key words: Sphingosine; Sphingosine kinase; Cisplatin; Cochlea; Cochlear hair cell 
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Introduction 
 The sphingolipids are a class of complex lipids that contain organic aliphatic amino alcohols such as 
sphingosine (Sph) (Nikolova-Karakashian et al. 2011; Van Brocklyn et al. 2012). Sphingolipids not only act as a 
cell structure component but also play multiple roles in physiologic functions, such as apoptosis, cell growth 
arrest, differentiation, senescence, migration, and adhesion (Maceyka et al. 2012). Ceramide (Cer), composed of 
Sph and a fatty acid, is converted to Sph by ceramidase. Sph is, in turn, phosphorylated to 
sphingosine-1-phosphate (S1P) by sphingosine kinase (Sk) (Taha et al. 2006). Nishimura et al. (2010) reported 
that Cer increased cochlear hair cell loss induced by gentamicin, whereas S1P protected cochlear hair cells 
against gentamicin. On the basis of previous reports, balance between these two metabolites is thought to be 
important for determination of hair cell fate (Cuvillier et al. 2000, 2001; Maceyka et al. 2002; Ogretmen et al. 
2004). However the effects of Sph on cochlear hair cells were remained unknown. 
 Sk is reportedly over expressed in many cancer cells (Xia et al. 2000; Nava et al. 2002; Guan et al. 
2011; Liu et al. 2010, 2012; Pchejetski et al. 2011). Over-expressed Sk renders the malignant cells resistant to 
chemoradiotheraphy and thus results in poor patient prognosis (Olivera et al. 1999; Van Brocklyn et al. 2005; 
Bonhoure et al. 2006; Hait et al. 2006; Li et al. 2009; Liu et al. 2010). Pharmacologic Sk inhibition has been a 
target of for anti-cancer therapy (French et al. 2003, 2006; Huwiler et al. 2011; Pyne et al. 2011). In addition, 
combination of Sk inhibitors and diverse anti-tumor drugs including cisplatin (CDDP) has been attempted in 
various cancer cell lines to increase toxicity toward tumor cells (Kedderis et al. 1995; Min et al. 2004, 2005; 
Alexander et al. 2006; Dickson et al. 2011; Ishitsuka et al. 2014; Liu et al. 2014). CDDP is a 
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platinum-containing anti-cancer agent used for various malignant tumors (Rybak et al. 2007; Ding et al. 2011). 
However, CDDP may cause several adverse effects such as nephrotoxicity and ototoxicity (Rybak et al. 2007; 
Ding et al. 2011). 
The effects of Sk inhibitors and Sph on cochlear hair cells are unknown. In addition, the effects of 
co-administration of Sk inhibitors and CDDP on hair cells have not been investigated. The present study 
therefore investigated (1) the expression of Sk in the rat cochlea, (2) the effect of CDDP on Sk activity in the 
cochlea, (3) the effect of an Sk inhibitor or Sph on cochlear hair cells, and (4) the effect of co-administration of 
an Sk inhibitor, Sph, or S1P and CDDP on cochlear hair cell death. 
 
Materials and method 
Animals 
Postnatal day 3 to 5 Sprague-Dawley rats were used. For immunohistochemical evaluation of Sk1 and 
Sk2 in the mature cochlea, adult female Sprague-Dawley rats were used. All animal procedures were carried out 
according to the guidelines of the Laboratory Animal Research Center of the University of Tsukuba. 
Sk expression in the cochlea 
The organs of Corti and lateral walls were dissected according to the methods of Van de Water et al. 
(1974) and Sobkowicz et al. (1993). Briefly, after the decapitation, the ear capsule was quickly exposed and 
broken out, and the organ of Corti and the lateral wall were isolated. I used the whole turn of the organ of Corti 
and the lateral wall. Total RNA was extracted from each cell using Trizol (Invitrogen, Carlsbad, CA, USA). 
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Reverse transcription of the extracted total RNA was performed using random primer (Random Primers, 
Invitrogen), RNaseOUT™ Recombinant Ribonuclease Inhibitor (Invitrogen), and SuperScript® II Reverse 
Transcriptase (Invitrogen). The mRNA expression levels of Sk1 and Sk2 were detected by conventional Reverse 
transcription-polymerase chain reaction (RT-PCR) with Taq polymerase enzyme (Takara, Shiga, Japan) by 
GeneAmp PCR System 9600 (Perkin Elmer, Tokyo, Japan). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was used as an internal control for RNA integrity (Nakayama et al. 2014). Gene sequences from Sk1 
(NM_001270811.1), Sk2 (NM_001012066.1), and GAPDH (NM_017008.4) were accessed from GenBank®. 
Primers for RT-PCR were designed using Primer-Blast software available at the NCBI (National Center for 
Biotechnology Information). 
The primer sequences of Sk1 were as follows: 
Sk1-F: 5`- CCCGGAGAGAACAAGGAACG -3` Sk1-R: 5`- CGGCCAGATCCTTTGAGGTT -3` 
The predicted amplicon sizes are 573. 
The primer sequences of Sk2 were as follows: 
Sk2-F: 5`- AACCATCATGGCGGGTTTGA -3` Sk2-R: 5`- TGAAAGCGTTGGGGGATGAA -3` 
The predicted amplicon sizes are 577. 
The primer sequences of GAPDH were as follows: 
GAPDH-F: 5`-AAGGTCATCCCAGAGCTGAA-3` GAPDH-R: 5`-GTTGAAGTCACAGGAGACAACC-3` 
The predicted amplicon sizes are 207. 
Western blot analysis was performed to detect protein expression levels of Sk1 and Sk2 at the organ 
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of Corti and lateral wall. The organs of Corti and lateral walls were dissected according to the methods of Van 
de Water et al. (1974) and Sobkowicz et al. (1993). Briefly, after the decapitation, the ear capsule was quickly 
exposed and broken out, and the organ of Corti and the lateral wall were isolated. I used the whole turn of the 
organ of Corti and the lateral wall. The organs of Corti and lateral walls were homogenized in PRO-PREP™ 
(Cosmo Bio, Tokyo, Japan). After centrifugation (13,000 rpm ×, 5 min, 4 ◦C), the supernatants were used for 
Western blot analysis. Appropriate volumes of the samples (10 μg/lane), were mixed with equal volumes of 
sample buffer (100 mM Tris–HCl, pH 6.8, 4 %SDS, 20 % glycerol, 10 % 2-mercaptoethanol, and 0.02 % 
bromophenolblue), heated at 95 ◦C for 5 min, and then subjected to SDS–PAGE using 4-20 % 
Mini-PROTEAN® TGX™ Gel (Bio-Rad, Hercules, CA, USA). The proteins were transferred by means of a 
semidry electroblotting system from the gels to polyvinylidene difluoride membranes for 1 h. The blots were 
then blocked with the primary antibodies for Sk1 (1: 500) (bs-2652R; Bioss Inc., Woburn, MA, USA) or Sk2 (1: 
500) (bs-2653R; Bioss Inc.) for 18 h at 4 ◦C. Skim milk powder was used for blocking buffer. Next, the blots 
were incubated with an appropriate second antibody, horseradish peroxidase-conjugated goat anti-rabbit IgG (1: 
2000) (7074S; Cell Signaling Technology, Denver, MA, USA), for 1 h. Immunoreactive bands were visualized 
using enhanced chemiluminescence (ECL kit; GE Healthcare Japan, Tokyo, Japan). Imaging was performed 
using ImageQuant LAS4000mini system (GE Healthcare Japan, Tokyo, Japan). 
Immunofluorescence staining was performed to detect expression of Sk1 and Sk2 in the organ of 
Corti. The basal turns of the organ of Corti from postnatal day 3 to 5 were dissected. They were fixed with 4% 
paraformaldehyde in phosphate-buffered saline (PBS) for 20 min and then blocked in blocking buffer (PBS/5% 
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normal goat serum (Sigma, St Louis, MO, USA) /0.3% Triton™ X-100 (Sigma)) for 60 min. Primary antibody 
for Sk1 (1: 100) (bs-2652R; Bioss Inc.) or Sk2 (1: 100) (bs-2653R; Bioss Inc.) were applied overnight at 4°C. 
The specimens were then incubated in Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) 
(1:100) (4412S; Cell Signaling Technology) with phalloidin (1:100) (Molecular Probes, Carlsbad, CA, USA) at 
room temperature in the dark for 1h. Phalloidin is a specific marker for cellular F-actin and labels the 
stereociliary arrays and the cuticular plates of hair cells (Tabuchi et al. 2007; Nishimura et al. 2010; Nakamagoe 
et al. 2010; Nakayama et al. 2014; Chi et al. 2015). Imaging was performed using a confocal laser scanning 
microscope (FLUOVIEW® FV10i, OLYMPUS, Tokyo, Japan). 
For experiments on immunohistochemical localizations of Sk1 and Sk2 in the rat cochlea, adult 
female Sprague-Dawley rats (SLC, Hamamatsu, Japan; 220–250 g) were deeply anesthetized with pentobarbital 
sodium. The cochleae were quickly removed from the temporal bone, were fixed with 4% paraformaldehyde, 
decalcified in 10% EDTA at 4°C, and then embedded in paraffin. The cochleae were cut into 5 μm-thick 
sections and mounted on slides (Hoshino et al. 2011). For antigen retrieval, the de-paraffinized sections were 
boiled for 15 min in an autoclave in citrate buffer (pH 6.0). Endogenous peroxidase activity was blocked 
through incubation with a 0.03% hydrogen peroxide solution for 20 min at room temperature. Each section was 
blocked in 5% goat serum (PK-6101; Vectastain Elite ABC Kit, Vector Laboratories, Burlingame, CA, USA) for 
30 min at room temperature. Primary antibody dilutions were prepared as follows: primary antibodies for Sk1 
(1: 50) (bs-2652R; Bioss Inc.) or Sk2 (1: 50) (bs-2653R; Bioss Inc.) at 4°C overnight, followed by incubation 
with the biotinylated goat anti-rabbit antibody (PK-6101; Vectastain Elite ABC Kit, Vector Laboratories) at 
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37°C for 30 min. The signal was developed with SignalStain® DAB Substrate kit (8059; Cell Signaling 
Technology), and all slides were counterstained with hematoxylin. Negative controls were treated with PBS 
instead of the primary antibodies (data not shown) (Coleman B et al. 2009; Tanaka S et al. 2012; Tang Y et al. 
2014). Imaging was performed using fluoroscence microscope BZ-X710 (KEYENCE, Osaka, Japan). 
Culture technique 
The basal turns of the organ of Corti were dissected and cultured. The cochlear explants were 
maintained in Dulbecco’s modified Eagle’s medium with 10 % fetal bovine serum (FBS), 25 mM HEPES, and 
30 U/mL penicillin. They were cultured in an incubator at 37 ◦C with 5 % CO2 at 95 % humidity. The cochlear 
cultures were maintained in the above-described medium overnight (8-12 h) and then exposed to a medium 
containing 5 μM CDDP for 48 h to assess the effects of Sph, the Sk inhibitor and S1P (Tabuchi et al. 2007; 
Nishimura et al. 2010; Nakamagoe et al. 2010; Nakayama et al. 2014; Chi et al. 2015). 
Chemicals 
2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole (SKi, an Sk inhibitor that inhibits both Sk1 and Sk2) 
and Sph were purchased from Echelon (Salt Lake City, UT, USA). S1P was purchased from Sigma. SKi, Sph 
and S1P were tested at 10-50 μM. SKi was initially dissolved in dimethyl sulfoxide (DMSO; Sigma) to 10 mM 
and stored at - 20 ◦C. Sph and S1P were initially dissolved in methanol (Wako Pure Chemical Industries, Osaka, 
Japan) to 10mM, and 2 mM, respectively, and stored at - 20 ◦C. Each agent was diluted in the culture medium to 
the final concentration immediately before use. The final concentrations of DMSO were 14-70 mM in SKi. 
Cytochemistry 
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After the explants had been cultured for 48 h in culture media containing 5 μM CDDP alone or 5 μM 
CDDP plus each concentration of SKi or Sph or S1P, they were fixed with 4 % paraformaldehyde PBS for 20 
min and then permeabilized with 5 % Triton™ X-100 (Sigma) in PBS with 10 % FBS for 10 min. The 
specimens were stained with phalloidin with a conjugated Alexa Fluorprobe (1:100; Molecular Probes) at room 
temperature for 1 h. 
Assessment of cochlear hair cell damage 
Imaging was performed using a confocal laser scanning microscope (FLUOVIEW® FV10i, 
OLYMPUS, Tokyo, Japan). The loss of hair cell was characterized as missing if no stereocilia and/or no 
cuticular plate were observed by phalloidin staining. I randomly assigned 3 parts from each culture. I counted 
the number of lost outer hair cells in 30 of outer hair cells in each part. The average of 3 parts was used to 
represent each culture (Tabuchi et al. 2007; Nishimura et al. 2010; Nakamagoe et al. 2010; Nakayama et al. 
2014; Chi et al. 2015). The average of three separate counts was used to represent each culture. 
Activation of caspase-3 
The protein expression levels of caspase-3 at the organs of Corti were detected by conventional 
Western blot. The organs of Corti were homogenized in PRO-PREP™ (Cosmo Bio, Tokyo, Japan). After 
centrifugation (13,000 rpm ×, 5 min, 4 ◦C), the supernatants were used for Western blot analysis. Appropriate 
volumes of the samples (10 μg/lane), were mixed with equal volumes of sample buffer (100 mM Tris–HCl, pH 
6.8, 4 %SDS, 20 % glycerol, 10 % 2-mercaptoethanol, and 0.02 % bromophenolblue), heated at 95 ◦C for 5 min, 
and then subjected to SDS–PAGE using 4-20 % Mini-PROTEAN® TGX™ Gel (Bio-Rad, Hercules, CA, USA). 
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The proteins were transferred by means of a semidry electroblotting system from the gels to polyvinylidene 
difluoride membranes for 1 h. The blots were blocked with the primary antibodies for β-actin (1: 1000) (4967S; 
Cell Signaling) or cleaved caspase-3 (1: 500) (9661S; Cell Signaling) for 18 h at 4 ◦C. Skim milk powder was 
used for blocking buffer. Next, the blots were incubated with an appropriate second antibody, horseradish 
peroxidase-conjugated goat anti-rabbit IgG (1: 2000) (7074S; Cell Signaling Technology), for 1 h. 
Immunoreactive bands were visualized using enhanced chemiluminescence (ECL kit; GE Healthcare Japan, 
Tokyo, Japan). The scanned immunoblot images were densitometrically analyzed with an ImageQuant 
LAS4000mini system (GE Healthcare Japan, Tokyo, Japan). The result of the cleaved caspase-3 protein/ β-actin 
protein assay was obtained from independent measurements (Nakayama et al. 2014). 
Sphingosine kinase assay 
The activity of Sk was quantified by using a Sphingosine Kinase Activity Assay (K-3500; Echelon) as 
described in the manufacturer's protocol. Briefly, organ of Corti cells were harvested and exposed to a medium 
containing 5 μM CDDP for 48 h. After the cells had been homogenized, 30 μg total proteins (16-20 organs of 
Corti) were incubated in reaction buffer containing 100 μM Sph and 10 μM ATP for 1 h at 37 ◦C. A 
luminescence-attached ATP detector was then added to stop the kinase reaction. The kinase activity was 
measured using a CentroXS3 LB960 microplate luminometer (Berthold Technologies, Bad Wildbad, Germany) 
(Cho et al. 2011; Guan et al. 2011). 
Data analysis 
All data were expressed as the means ± S.E.Ms. Statistical analysis was performed using unpaired t 
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-tests or one-way analysis of variance (ANOVA) followed by Bonferroni post hoc tests, as required (StatView 
5.0). Probability values of less than 0.05 were considered significant. 
 
Results 
Sk expression in the cochlea 
Expression of Sk1 and Sk2 was examined using the RT-PCR technique, Western blot analysis, and 
immunohistochemistry. Sk1 and Sk2 mRNAs were clearly detected in the organ of Corti and the lateral wall by 
nonquantitative RT-PCR analysis. Sk1 and Sk2 proteins were also clearly detected in the organ of Corti and the 
lateral wall by Western blot analysis (Fig. 1A, B). Immunofluorescence of Sk in the organ of Corti revealed the 
presence of both Sk subtypes in the inner and outer hair cells (Fig. 2). In addition, immunohistochemical 
evaluation for adult rats demonstrated that both Sk subtypes were expressed in the mature cochlea (Fig. 3). 
Sk activation by CDDP treatment 
Changes in Sk activity induced by CDDP exposure were examined using organ of Corti explants. 
Compared with the non-CDDP exposed samples, 5 μM CDDP significantly increased Sk activity at 48 h (Fig. 4; 
unpaired t -test: P < 0.05 in the 5 μM subgroups [n=4] as compared with the control group [n=3]). 
Effects of SKi on cochlear hair cells 
In control explants maintained in the initial medium for 48 h without exposure to CDDP, almost all 
hair cells including 1 row of inner hair cells and 3 rows of outer hair cells were present (Fig. 5A). The effects of 
SKi and DMSO as solvents on the outer hair cells were examined and compared with the control explants. 
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DMSO alone did not induce hair cell loss (data not shown). No significant hair cell loss occurred when the 
explants were cultured for 48 h in the medium containing 10 (n = 15) or 20 (n = 14) μM SKi alone (Fig. 5B). 
However, 50 μM SKi (n = 15) significantly induced hair cell loss as compared with the control group (n =8) 
(one-way ANOVA and Bonferroni test: P < 0.05 in the 50 μM subgroups). 
Effects of SKi on CDDP ototoxicity 
The effect of SKi on CDDP-induced cochlear hair cell loss was examined using organ of Corti 
explants. The explants treated with 5 μM CDDP alone showed reduced numbers of outer hair cells (Fig. 6A). 
When compared with the explants treated with CDDP alone (the CDDP control group, n = 22), SKi significantly 
and dose-dependently increased the ratio of outer hair cell loss induced by CDDP at the concentrations of 10 (n 
= 9), 20 (n = 10), and 50 (n = 10) μM (Fig. 6B; one-way ANOVA and Bonferroni test: P < 0.05 in the 10, 20, 
and 50 subgroups). 
Activation of caspase-3 under SKi ototoxicity 
The protein expression levels of cleaved caspase-3 in the cochlea were examined by Western blot 
analysis. Cleaved caspase-3 was expressed in the cochlea treated with 20 μM SKi alone, 5 μM CDDP alone, and 
20 μM SKi plus 5 μM CDDP within 48 h (Fig. 7A). In addition, the group treated with 20 μM SKi plus 5 μM 
CDDP expressed a significantly higher level of cleaved caspase-3 than did the groups treated with 20 μM SKi 
alone or 5 μM CDDP alone at 48 h (Fig. 7B; one-way ANOVA and Bonferroni test: P < 0.05, n = 6 in each 
group). 
Effects of Sph on cochlear hair cells 
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The effects of Sph and methanol as solvents on outer hair cells were examined. No significant hair 
cell loss occurred when explants were cultured for 48 h in the medium containing methanol alone (data not 
shown) and 10 (n = 12) or 25 (n = 18) μM Sph (Fig. 8A). However, 50 μM Sph (n = 19) significantly induced 
hair cell loss as compared with the control group (n = 12) (Fig. 8B; one-way ANOVA and Bonferroni test: P < 
0.05 in the 50 μM subgroup). 
Effects of Sph on CDDP ototoxicity 
The effect of Sph on CDDP-induced cochlear hair cell loss was examined using organ of Corti 
explants (Fig. 9A, B). When compared with the explants treated with CDDP alone (n = 22), Sph increased the 
ratio of outer hair cell loss induced by CDDP at the concentrations of 10 (n = 11), 25 (n = 11), and 50 (n = 14) 
μM in a dose-dependent manner at 48 h (one-way ANOVA and Bonferroni test:P < 0.05). 
Activation of caspase-3 under Sph ototoxicity 
Although cleaved caspase-3 was not detected in the organ of Corti explants without Sph, cleaved 
caspase-3 was expressed in cochlea treated with 25 or 50 μM Sph alone (Fig. 10A). In addition, the group 
treated with 50 μM Sph alone (n = 6) showed significantly increased expression levels of cleaved caspase-3 as 
compared with the 25 μM Sph alone group (n = 5) and the group without Sph (n = 5) (Fig. 10B; one-way 
ANOVA and Bonferroni test: P < 0.05). 
Effects of S1P on CDDP ototoxicity 
The effect of S1P on CDDP-induced cochlear hair cell loss was examined using organ of Corti 
explants (Fig. 11A, B). When compared with the explants treated with CDDP alone (n = 22), S1P did not exhibit 
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any significant effect on CDDP-induced hair cell loss at 10 (n = 10) or 20 (n = 10) μM at 48h. However, S1P 
decreased the ratio of outer hair cell loss at 50 (n = 12) μM (one-way ANOVA and Bonferroni test:P < 0.05). 
Discussion 
 Sk is a key enzyme in the pathway of phospholipid catabolism and controls the levels of two 
bioactive sphingolipids, Sph and S1P (Fig. 12). Two Sk isoforms, Sk1 and Sk2, are known (Pitson. 2011; 
Maceyka et al. 2012). These isoforms are located on separate genes but are highly homologous, with a similarity 
percentage of approximately 80%. Molecular weight of Sk1 is approximately 43 kDa and Sk2 is approximately 
65 kDa (Wattenberg et al.2006). Unlike Sk1, Sk2 possesses an extended N-terminal tail (Liu et al. 2000; 
Alemany et al. 2007; Hait et al. 2009). The present PCR study and Western blot analysis demonstrated that 
mRNAs and proteins of both Sk subtypes were expressed in the cochlea (Fig. 1A, B). The immunofluorescence 
staining for postnatal day 3 to 5 rats and immunohistochemical evaluation for adult rats demonstrated that both 
Sk subtypes were expressed in the cochlea (Fig. 2, Fig. 3). Some functional redundancy was thought to exist 
between Sk1 and Sk2 because major phenotypes were not observed in either Sk1 or Sk2 single-knockout mice 
(Mizugishi et al. 2005). In in vitro studies, it has been reported that Sk1 causes cell proliferation, whereas Sk2 
plays a role in both cell growth and apoptosis (Igarashi et al. 2003; Liu et al. 2003; Okada et al. 2005; Olivera et 
al. 1999; Pitman et al. 2010; Pitson. 2011). However, the functional differences between these subtypes were not 
fully understood. 
SKi, used in this study, inhibits both Sk1 and Sk2 (Pitson 2011; Pyne et al. 2011). SKi itself induced 
cochlear hair cell death at a high concentration of 50 μM (Fig. 5A, B). In addition, when SKi was 
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co-administrated with CDDP, it reinforced the ototoxicity of CDDP even at the low concentrations at which SKi 
itself did not show any ototoxicity (Fig. 6A, B). The mechanisms of Sk inhibitor-related cell death are not fully 
known. However, it has been reported that the apoptotic pathway is one of the mechanism leading to cell death 
by Sk inhibitors (Cuvillier et al. 2000, 2001; Hait et al. 2006; Phillips et al. 2007; Kanno et al. 2011; Young et al. 
2013). I examined the apoptotic pathway of the organ of Corti by detecting cleaved caspase-3. SKi induced the 
cleavage of caspase-3 in the organ of Corti. Furthermore, SKi accelerated the CDDP-induced apoptotic death of 
hair cells (Fig. 7A, B). On the basis of these findings, I can assume that cochlear hair cell death induced by SKi 
is related to apoptosis. 
The exogenous administration of Sph showed ototoxicity when administered at a high concentration, 
but not at a low concentration (Fig. 8 A, B). Similar to SKi, when Sph was co-administered with CDDP, even at 
a low concentration, it augmented the ototoxicity of CDDP (Fig. 9A, B). Western blot analysis also showed that 
the apoptotic pathway was involved in hair cell death induced by Sph (Fig. 10A, B). Sph has been found to 
break plasma membrane permeability barrier (Contreras et al. 2006; Jiménez-Rojo et al. 2014). Also 
phytosphingosine, a member of the Sph family causes a direct permeabilization of the plasma membrane of 
yeast (Veerman et al. 2010). It is assumed that exogenous administration of Sph caused a permeabilization of the 
plasma membrane to the outer hair cells and an influx of Sph which resulted to apoptosis. On the other hand, 
S1P protected hair cells against CDDP (Fig. 11A, B). This result is in accordance with the protective effects of 
S1P on gentamicin ototoxicity (Nishimura et al. 2010). S1P exerts its cellular responses through a family of 5 
G-protein-coupled S1P receptors (S1PRs) known as S1PR1-5 (Nakayama et al. 2014). S1PR1-3 are expressed in 
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the spiral ganglion and in the organ of Corti (Herr et al. 2007; Kono et al. 2007; Nakayama et al. 2014). 
Especially S1PR2 is detected in the supporting cells and in the inner and outer sensory hair cells (Herr et al. 
2007). S1P exerts its cochlear protection against gentamicin ototoxicity via activation of S1PR2 (Nakayama et al. 
2014). From those previous reports exogenous administration of S1P might protect hair cells against CDDP 
ototoxicity via activation of S1PR2 expressed in hair cells. 
 Cer, Sph and S1P are thought to be important for determination of hair cell fate (Cuvillier et al. 2000, 
2001; Maceyka et al. 2002; Ogretmen et al. 2004). S1P causes cell survival, while Cer and Sph cause cell death 
(Fig. 12) (Spiegel et al. 1999; Pyne et al. 2002). Sph has been reported as promoter of apoptosis 
(Nikolova-Karakashian et al. 2000). Cytochrome c release from mitochondria and activation of caspases-8 and 
caspase-9 were observed with Sph in Jurkat cells (Cuvillier et al. 2000). Sph-mediated apoptosis requires Bax, 
pro-apoptotic member of the Bcl-2 protein family. Sph-mediated apoptosis requires translocation of Bax to the 
mitochondria and its activation that induces the release of cytochrome c and Smac/Diablo from the mitochondria 
in rhabdomyosarcoma cell line (Phillips et al .2007). Sph-induced apoptosis is also observed in hippocampal 
neurons and astrocytes (Kanno et al. 2011). On the other hand S1P has been considered as a counterbalance 
(Payne et al. 2002; Oskouian et al. 2010). In Jurkat cells, caspase-3 and caspase-7 activation by the translocation 
of cytochrome c and Smac/Diablo from mitochondria could be prevented by S1P (Cuvillier et al. 1998; Cuvillier 
et al. 2001). S1P is produced by phosphorylation of Sph due to Sk. Sk therefore regulates the effects of 
pro-apoptotic Sph and pro-proliferative S1P (Fig. 12). Enforced expression of Sk can protect cancer cells from 
apoptosis (Cuvillier et al. 2008). Inhibiting Sk and downregulating S1P is thus a rational therapeutic target in 
17 
 
cancer (Reynolds et al. 2004; Min et al. 2004, 2005; Cuvillier et al. 2008; Dickson et al. 2011; Pyne et al. 2011). 
From the view-point of cancer treatment, modulating the levels of sphingolipids like Sk inhibition is expected to 
augment the effect of existing anti-cancer drugs such as CDDP (Min et al. 2004, 2005; Alexander et al. 2006; 
Dickson et al. 2011; Ishitsuka et al. 2014; Liu et al. 2014). In D. discoideum, overexpressing Sk or null for S1P 
lyase, the enzyme that degrades S1P, have decreased sensitivity to CDDP, whereas cells null for the Sk or 
overexpressing S1P lyase are more sensitive (Min et al. 2004, 2005; Alexander et al. 2006). Some researchers 
suggested that inhibition of the sphingosine kinase synergistically increased sensitivity to CDDP and induced 
cell death (Min et al. 2004, 2005; Ishitsuka et al. 2014; Liu et al. 2014). Several survival pathways including, the 
extracellular signal-regulated kinase mitogen-activated protein kinase pathway, the phosphatidylinositol 
3-kinase/Akt/mTOR pathway and the c-Jun N-terminal kinase pathway suggested to play key roles in synergy of 
Sk inhibitor and CDDP (Min et al. 2005; Ishitsuka et al. 2014; Liu et al. 2014). Also this synergy is suggested 
that Sk inhibitor increased the concentrations of CDDP in cell by downregulation of drug transport proteins (Liu 
et al. 2014). I showed for the first time the phenomenon that Sk inhibitor has an ototoxic effect by its 
pro-apoptotic nature which will also enhances the CDDP-induced apoptotic death results in ototoxicity (Fig. 7 A, 
B). We should be aware of co-administration of Sk inhibitor and an ototoxic drug in clinical usage might 
increase the possibility of ototoxicity. Although in my study I could neither proved the direct interaction of 
sphingolipids with CDDP nor the changes of sphingolipid in the cell. Further research will be necessary to 
reveal the exact protective and degenerative mechanisms of sphingolipids in hair cell. 
CDDP activated Sk in the organ of Corti (Fig. 4). Activation of Sk seems reasonable for the protection 
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of the organ of Corti against CDDP because Sk functions by increasing S1P and decreasing Sph. Sk activity and 
expression are also stimulated by hypoxia (Ader et al. 2009; Ahmad et al. 2006). Hypoxia generates S1P as a 
result of increased activity of Sk and enhance the proliferation of smooth muscle cells (Yun et al. 2002). 
Hypoxia increases Sk activity via reactive oxygen species (ROS) which are apoptotic (Ader et al. 2009). This is 
same phenomenon shown in this study. To protect from cytotoxic agent such as CDDP, it is assumed that cell 
activate Sk for producing protective S1P. CDDP induces ROS in hair cells and consequently causes apoptosis 
(Rybak et al. 2007). ROS is also induced by several sphingosine kinase inhibitors including SKi (Chatzakos et 
al. 2012; Hagihara et al. 2014; Hamada et al. 2014). It is presumed that Sk inhibitor enhance CDDP ototoxicty 
synergistically by increasing more ROS than CDDP alone and impeding the intrinsic cell protective mechanism 
of the cochlea against CDDP ototoxicity. 
 In conclusion, SKi and Sph showed ototoxicity by themselves and enhanced the apoptotic death of 
outer hair cells in the presence of CDDP. Conversely S1P showed otoprotective effect on CDDP ototoxicity. 
From the view-point of growing evidence that Sk inhibitors are effective in the treatment of cancer and 
inflammatory diseases, more attention should be paid to the possibility of their adverse effects, including 
ototoxicity, before consideration of their clinical usage. 
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Figure Captions 
 
Fig. 1 Sk expression in the cochlea. (A) RT-PCR analysis demonstrated that Sk1 and Sk2 were expressed in the 
organ of Corti (OC) and lateral wall (LW). GAPDH primers served as the cDNA loading control. (B) Western 
blot analysis demonstrated that Sk1 and Sk2 were expressed in OC and LW. M: marker; NC: negative control; 
L: liver (positive control). 
 
Fig. 2 Sk expression in the pup cochlea. Immunofluorescence staining demonstrated that Sk1 and Sk2 were 
expressed in the sterocilia of hair cells and cellular membrane. The outer and inner hair cells stained with Sk1. 
(A) Sk1 (indicated in green) (B) phalloidin (indicated in red) (C) Merged images of Sk1 and phalloidin. Sk1 is 
expressed in cytoplasm. (D) Sk1 (indicated in green) (E) phalloidin (indicated in red) and DAPI (indicated in 
blue) (F) Merged images of Sk1, phalloidin and DAPI. The outer and inner hair cells stained with Sk2. (G) Sk2 
(indicated in green) (H) phalloidin (indicated in red) (I) Merged images of Sk2 and phalloidin. Sk1 is expressed 
in cytoplasm. (J) Sk2 (indicated in green) (K) phalloidin (indicated in red) and DAPI (indicated in blue) (L) 
Merged images of Sk2, phalloidin and DAPI. Scale bar: 40 μm. O: outer hair cell. I: inner hair cell 
 
Fig. 3 Sk expression in the mature cochlea. Immunofluorescence staining demonstrated that Sk1 ((A) X400) and 
Sk2 ((B) X400) were expressed in the organ of Corti. Scale bar: 100 μm. 
 
Fig. 4 Sk activation by CDDP. 48 h CDDP treatment activated Sk in the organ of Corti (unpaired t -test: *P < 
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0.05 in the 5 μM subgroups). 
 
Fig. 5 Effects of SKi on cochlear hair cells. Organs of Corti were cultured with 0 (control) to 50 μM SKi for 48 
h. (A) Representative microphotographs of cochlear hair cells. Scale bar: 40 μm. (B) Quantitative analysis of 
outer hair cell loss induced by SKi. SKi increased hair cell loss at 50 μM as compared with the control group 
(one-way ANOVA and Bonferroni test: *P < 0.05). 
 
Fig. 6 Effects of SKi on CDDP ototoxicity. Organs of Corti were cultured with 5 μM CDDP alone or with 5 μM 
CDDP plus 10-50 μM SKi for 48 h. (A) Representative microphotographs. Scale bar: 40 μm. (B) Quantitative 
analysis of outer hair cell loss. Each concentration of SKi increased hair cell loss as compared with CDDP alone 
(one-way ANOVA and Bonferroni test: *P < 0.05). 
 
Fig. 7 Cleaved caspase-3 expression under SKi ototoxicity. (A) Representative blot images. β-Actin was used as 
an the internal control. Although cleaved caspase-3 was not detected at 0 h, expression of cleaved caspase-3 was 
clearly detected within 48 h in the 20 μM SKi alone, 5 μM CDDP alone, and 20 μM SKi plus 5 μM CDDP 
groups. (B) Quantitative analysis of cleaved caspase-3 expression. 20 μM SKi plus 5 μM CDDP increased 
cochlear hair cell loss as compared with 20 μM SKi alone and 5 μM CDDP alone at 48 h (one-way ANOVA and 
Bonferroni test: *P < 0.05). 
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Fig. 8 Effects of Sph on cochlear hair cells. Organ of Corti explants were cultured with or without Sph. (A) 
Representative microphotographs. Scale bar: 40 μm. (B) Quantitative analysis of outer hair cell loss induced by 
Sph. Organs of Corti were cultured with 10-50 μM Sph for 48 h. Sph increased hair cell loss at 50 μM (one-way 
ANOVA and Bonferroni test: *P < 0.05). 
 
Fig. 9 Effects of Sph on CDDP ototoxicity. Organs of Corti were cultured with 5μM CDDP alone or with 5 μM 
CDDP plus 10-50 μM Sph for 48 h. (A) Representative microphotographs. Scale bar: 40 μm. (B) Quantitative 
analysis of outer hair cell loss. Each concentration of Sph increased hair cell loss as compared with the culture 
with CDDP alone (one-way ANOVA and Bonferroni test: *P < 0.05). 
 
Fig. 10 Cleaved caspase-3 expression under Sph ototoxicity. (A) Representative blot images. β-actin was used 
as the internal control. Cleaved caspase-3 was not detected in the control organs of Corti (without Sph). Cleaved 
caspase-3 was detected in the explants exposed to Sph for 48 h. (B) Quantitative analysis of cleaved caspase-3. 
Cleaved caspase-3 was expressed at significantly higher levels in the 50 μM Sph group at 48 h than in the 25 
μM Sph group and the group without Sph(one-way ANOVA and Bonferroni test: *P < 0.05). 
 
Fig. 11 Effects of S1P on CDDP ototoxicity. Organs of Corti were cultured with 5 μM CDDP plus 10-50 μM 
S1P for 48 h. (A) Representative microphotographs of hair cells. Scale bar: 40 μm. (B) Quantitative analysis of 
outer hair cell loss. S1P decreased hair cell loss at 50 μM compared with the culture with CDDP alone (one-way 
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ANOVA and Bonferroni test: *P < 0.05). 
 
Fig. 12 A schematic panel of roles of ceramide, sphingosine, sphingosine-1-phosphate, sphingosine kinase and 
SKi (sphingosine kinase inhibitor). I showed in my study that sphingosine and SKi has an apoptotic, cytotoxic 
effect for hair cells and sphingosine-1-phosphate has a protective effect against cisplatin.  
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